Pallottini V, Bulzomi P, Galluzzo P, Martini C, Marino M
Department of Biology, University Roma Tre, Viale G. Marconi 446, I-00146 Roma, Italy.
Infect Disord Drug Targets. 2008 Mar;8(1):52-60. doi: 10.2174/187152608784139631.
Adipose tissue has recently been described as one of the major endocrine gland that plays a role in energy homeostasis, lipid metabolism, immune response, and reproduction. An excess of white adipose tissue, caused by a complex interaction between genetic, hormonal, behavioral, and environmental factors, results in obesity: a heterogeneous disorder that predisposes humans to a variety of diseases. Among several hormones, estrogens promote, maintain, and control the typical distribution of body fat and adipose tissue metabolism through still unknown mechanisms. These steroids are known to regulate fat mass, adipose deposition and differentiation, and adipocyte metabolism. Moreover, estrogen deficiency results in increases in adipose tissue, preferentially in visceral fat, which would link obesity to the susceptibility of related disorders. In this review the role of estrogens in adipose tissue differentiation and in the protection against the onset of obesity will be discussed with particular attention being drawn to the underlying molecular mechanisms mediated by estrogen receptor isoforms ERalpha and ERbeta.
脂肪组织最近被描述为主要内分泌腺之一,在能量稳态、脂质代谢、免疫反应和生殖中发挥作用。由遗传、激素、行为和环境因素之间复杂的相互作用导致的白色脂肪组织过多会导致肥胖:这是一种异质性疾病,使人类易患多种疾病。在几种激素中,雌激素通过仍不清楚的机制促进、维持和控制身体脂肪的典型分布及脂肪组织代谢。已知这些类固醇可调节脂肪量、脂肪沉积和分化以及脂肪细胞代谢。此外,雌激素缺乏会导致脂肪组织增加,尤其是内脏脂肪增加,这将肥胖与相关疾病的易感性联系起来。在这篇综述中,将讨论雌激素在脂肪组织分化和预防肥胖发生中的作用,并特别关注由雌激素受体亚型ERα和ERβ介导的潜在分子机制。